Skip to main content

Table 1 Comparison of the characteristics of the satisfied and dissatisfied patients with their management at the TBD-RC and of the patients who accepted or not their diagnosis

From: Lyme borreliosis and medical wandering: what do patients think about multidisciplinary management? A qualitative study in the context of scientific and social controversy

Characteristics of the patients

Total N = 349 (%)

Satisfied patients N = 297 (%)

Dissatisfied patients N = 52 (%)

p-value

Diagnostic acceptance N = 280 (%)

No Diagnostic acceptance N = 69 (%)

p-value

Age, (years), median [IQR]

48 [35,62]

49 [35, 62]

42.5 [33,58]

0.393

48 [34,62]

48 [37,60]

0.558

Male

146 (41.8)

122 (41.1)

24 (46.2)

0.494

117 (41.8)

29 (42.0)

0.971

Lifestyle

   

0.676

  

0.708

 Home in a rural area

72 (20.6)

62 (20.9)

10 (19.2)

 

56 (20.0)

16 (23.2)

 

 Employment in rural areas/forest

17 (4.9)

14 (4.7)

3 (5.8)

 

15 (5.4)

2 (2.9)

 

 Forest-based leisure activities

249 (71.4)

213 (71.7)

36 (69.2)

 

201 (71.8)

48 (69.6)

 

 No exposure

11 (3.2)

8 (2.7)

3 (5.8)

 

8 (2.9)

3 (4.4)

 

Past history of tick bite

234 (67.1)

201 (67.7)

33 (63.5)

0.551

189 (67.5)

45 (65.2)

0.718

Past history of erythema migrans

97 (27.9)

90 (30.3)

7 (13.7)

0.015

82 (29.3)

15 (22.1)

0.233

Patients referred by a physician with a letter

313 (89.7)

264 (88.9)

49 (94.2)

0.218

250 (89.3)

63 (91.3)

0.015

General Practitioner

241 (69.1)

200 (67.3)

41 (78.9)

 

183 (65.4)

58 (84.1)

 

Specialist physician

59 (16.9)

51 (17.2)

8 (15.4)

 

55 (19.6)

4 (5.8)

 

Emergency unit physician

13 (3.7)

13 (4.4)

0 (0.0)

 

12 (4.3)

1 (1.5)

 

No letter, patient self-referral

36 (10.3)

33 (11.1)

3 (5.8)

 

30 (10.7)

6 (8.7)

 

Duration (days) of chief complaints prior to consultation at TBD-RC, median [IQ 25,75]

425.5 [140.5, 1208.5]

416 [133, 1155]

804 [230, 1679]

0.021

382 [128, 1174]

561 [249, 1437]

0.017

Positive serological test*

111 (31.8)

98 (33.0)

13 (25.0)

0.118

91 (32.5)

20 (28.9)

0.869

Final diagnosis at TBD-RC

   

0.016

  

0.007

 Confirmed LB

48

47 (15.8)

1 (1.9)

 

47 (16.8)

1 (1.5)

 

 Possible LB

31

29 (9.8)

2 (3.9)

 

24 (8.6)

7 (10.1)

 

 PTLDS/sequelae

34

27 (9.1)

7 (13.5)

 

24 (8.6)

10 (14.5)

 

 Other diagnoses

236

194 (65.3)

42 (80.8)

 

185 (66.1)

51 (74.0)

 

Antibiotic therapy prescribed before TBD-RC

228 (65.3)

192 (64.7)

36 (69.2)

0.522

179 (63.9)

49 (71.0)

0.268

Antibiotic therapy > 4 weeks

71 (20.3)

55 (18.5)

16 (30.8)

0.043

49 (17.5)

22 (31.9)

0.008

Non-recommended treatments **

61 (17.5)

47 (15.8)

14 (26.9)

0.052

43 (15.4)

18 (26.1)

0.036

  1. LB Lyme borreliosis, PTLDS Post-Treatment Lyme Disease Syndrome, IQR Inter quartile range, TBD-RC  Tick-Borne Diseases Reference Center, *A positive serological test = IgM and/or IgG positive in ELISA and WB if the tick bite occurred less than 6 weeks ago; or IgG positive only if the tick bite occurred more than 6 weeks ago, ELISA Enzyme-Linked Immunosorbent Assay, WB Western-Blot; **Non-recommended treatment: > 8 weeks of antibiotics and/or associated antimicrobials.